封面
市場調查報告書
商品編碼
1198701

泌尿外科設備市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Urology Devices Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在預測期內(2022-2027 年),全球泌尿外科設備市場將以 6.35% 的增長率增長。

COVID-19 的全球傳播使許多醫療保健機構擠滿了危重病人和透析機、內窺鏡和碎石機等醫療設備。 COVID-19 會導致個人出現急性呼吸窘迫和急性腎損傷。 當患者的身體無法清除體內多餘的廢物和液體時,就會發生多器官衰竭和腎衰竭。 由於透析機用於治療患者,泌尿外科設備市場將對 COVID-19 產生有益影響。 然而,在大流行期間,泌尿外科實踐有所下降。 因此,COVID-19 將對所研究的市場產生不同的影響。

推動市場增長的主要因素是泌尿外科設備的高發率、老年人口的增加和技術進步。

根據美國泌尿外科協會基金會 (AUAF) 的數據,良性前列腺增生症 (BPH)、尿失禁 (UI)、尿路感染 (UTI)、腎結石和輸尿管結石是最常見的泌尿外科器械之一。 根據美國國家醫學研究所的數據,2020 年 7 月,尿路感染影響全球約 1.5 億人。 大約 11% 的女性每年去看醫生一次以治療尿路感染。 尿路感染 (UTI) 是影響所有年齡段人群的最常見的微生物疾病之一。 全世界每年約有 1.5 億人患有尿路感染。 糖尿病患者發生尿路感染的風險很高。 排尿困難和器官損傷等並發症與尿路結石有關,並且隨著世界糖尿病人口的增加而增加。

此外,根據 2020 年 8 月發表在《國際分子醫學雜誌》上的一篇論文,腎結石,也稱為腎結石或尿路結石,是最古老的醫學疾病之一。 ...顯然 ... 據估計,有 11% 的人會在一生中的某個時候患上腎結石,而且全世界腎結石的患病率和發病率都在上升。 然而,尿石症的總體患病率為11.2%,48.8%的一級親屬患有該病。 此外,男性患尿路結石的可能性是女性的 1.8 倍。

因此,由於與泌尿外科設備相關的高發病率和健康並發症,對管理它們的醫療干預的需求不斷增加,這反過來又推動了泌尿外科設備市場。它是

泌尿外科設備市場趨勢

腎臟疾病領域預計將佔據最高市場份額

腎臟有多種疾病,如腎囊腫、囊性腎病、慢性腎病、溶血性尿毒症綜合徵、軟玉狼瘡等。 由於許多腎臟疾病會導致腎功能衰竭,因此需要及早診斷以便及時治療。

根據 Onecia Benjamin 和 Sarah L. Lappin 於 2021 年 9 月發表的一篇論文,終末期腎病 (ESRD) 每年影響美國超過 500,000 人。 CKD 的患病率隨著年齡的增長而增加,該病在 60 歲以上的人群中進展最快。 18 至 44 歲人群的頻率為 6.0%,65 歲及以上人群的頻率為 38.1%。

美國國家糖尿病、消化和腎臟疾病研究所 (NIDDK) 2020,ESKD,也稱為終末期腎病 (ESRD),影響美國近 786,000 人,其中 71% 接受透析,29% 接受腎移植將需要。 據說 ESKD 會影響受影響的男性中的三分之一和女性中的二分之一。 然而,大多數人在早期階段仍未得到診斷,最終在世界各地死亡。

因此,意識的提高、政府通過報銷提供的支持以及產品創新以開發低成本和有效的治療方法是預計在預測期內推動市場發展的因素。我在這裡。

北美主導市場,預計在預測期內會出現同樣的趨勢

目前,北美在泌尿外科市場擁有壓倒性的實力,這種勢頭有望在未來持續下去。 良性前列腺增生症 (BPH) 是泌尿外科市場中最未開發的部分之一。 幾家總部位於美國的公司正致力於通過合作或收購來升級該領域的設備。

該地區在與尿路結石診斷技術相關的技術創新方面取得了重大進展。 在 Pranita D. Tamma 於 2020 年 11 月發表於美國傳染病學會的一篇論文中,一名婦女在尿路常規檢查中被診斷出患有大腸桿菌,這種大腸桿菌對最後一道防線抗生素粘菌素具有耐藥性結石。據觀察,他被感染了。 粘菌素耐藥細菌的發現被認為是一個主要問題。 此外,CDC 還與其他組織合作制定了在美國預防與醫療保健相關的感染(例如與導管相關的尿石)的指南。 尿石症造成重大的社會和個人負擔,導緻美國每年有大量就醫。 這種情況增加了泌尿外科設備的銷量並帶動了市場。

因此,技術進步、醫院泌尿外科病例比例高以及資金增加預計將成為預測期內泌尿外科設備市場增長的主要因素。

泌尿外科器械市場競爭者分析

泌尿外科設備市場競爭激烈,由幾家大型企業組成。 隨著技術進步和產品創新不斷,中小企業有望通過以更低的價格推出新設備來提高其市場佔有率。 百特、波士頓科學、C.R. Bardo、美敦力和西門子等公司佔據了相當大的市場份額。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 泌尿外科設備的高發率
    • 老年人口增加
    • 技術進步
  • 市場製約因素
    • 嚴格的醫療器械驗證監管政策
    • 泌尿外科設備成本高
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於價值的市場規模:百萬美元)

  • 按產品分類
    • 醫療設備
      • 透析器
      • 內窺鏡和內窺鏡系統
      • 激光和微積分粉碎機
      • 其他設備
    • 按耗材和配件
      • 透析相關耗材
      • 導絲和導管
      • 支架
      • 活檢裝置
      • 其他消耗品和配件
  • 按疾病分類
    • 腎臟疾病
    • 泌尿系統癌症、良性前列腺增生
    • 盆腔器官脫垂
    • 其他疾病
  • 最終用戶
    • 醫院和診所
    • 透析中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Baxter International Inc.
    • Boston Scientific Corporation
    • Becton, Dickinson and Company
    • Cook Medical Incorporated
    • Stryker Corporation
    • Fresenius Medical Care AG & Co. KGaA
    • Intuitive Surgical Inc.
    • Karl Storz SE & Co. KG
    • Medtronic PLC
    • Olympus Corporation

第7章 市場機會今後動向

簡介目錄
Product Code: 60485

The global urology devices market is growing at a rate of 6.35% during the forecast period (2022-2027).

The global spread of COVID-19 has flooded many healthcare institutions with severely ill patients and medical equipment such as dialysis machines, endoscopes, and lithotripsy machines. COVID-19 causes acute respiratory distress and acute renal damage in individuals. Multi-organ failure and renal failure can occur when the patient's body cannot remove excess waste and fluids from the body. As a result of the use of dialysis equipment in the treatment of patients, the urology device market has a beneficial impact on COVID-19. However, urology practices have decreased during the pandemic. Thus, COVID-19 has a mixed impact on the market studied.

The key factors propelling the market growth include a high incidence of urologic conditions, a rising senior population, and technological advancements.

According to the American Urological Association Foundation (AUAF), benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections (UTIs), and kidney and ureteral stones are among the most common urological diseases. The United States According to the National Institute of Medicine July 2020, urinary tract infection affects approximately 150 million people globally. In addition, about 11% of women visit one physician yearly for urinary tract infection treatment. Urinary tract infections (UTIs) are among the most common microbial diseases affecting people of all ages. Globally, UTIs affect around 150 million people every year. Diabetic patients have a higher risk of developing UTIs. With a global increase in the diabetic population, complications like dysuria and organ damage are associated with UTIs, which are also rising.

Additionally, according to the article published in the International Journal of Molecular medicine in August 2020, Kidney stone disease, also known as nephrolithiasis or urolithiasis, is one of medicine's oldest diseases. It is estimated that 11% of people will develop kidney stones at some point in their lives, and the prevalence and incidence of kidney stones are increasing worldwide. However, the overall prevalence of urolithiasis was 11.2 %, with 48.8 % having a first-degree relative with the disease. Males were 1.8 times more likely than females to have urolithiasis.

Hence, with the high incidence rates and health complications associated with urological diseases, there is an increasing demand for healthcare interventions to manage them, which, in turn, is propelling the market of urology devices market.

Urology Devices Market Trends

Kidney Disease Segment Expected to Hold the Highest Market Share

The various kidney diseases include renal cyst, cystic kidney diseases, chronic kidney disease, hemolytic-uremic syndrome, and lupus nephrite, among others. Most kidney diseases lead to kidney failure, which requires early diagnosis for prompt treatment.

According to the article published in the National Institutes of Health in September 2021 by Onecia Benjamin and Sarah L. Lappin., End-stage renal disease (ESRD) affects more than 500,000 persons in the United States annually. The prevalence of CKD rises with age, with persons aged 60 and up experiencing the fastest development. The frequency is 6.0 % among those aged 18 to 44 and 38.1% among those aged 65 and up.

National Institute on Diabetes and Digestive and Kidney Diseases (NIDDK) in 2020, ESKD, also known as an end-stage renal disease (ESRD), affects almost 786,000 people in the United States with 71% requiring dialysis and 29% requiring a kidney transplant. ESKD affects three men and every two women who develop it. However, most of the population remains undiagnosed in the early stages, eventually leading to death worldwide.

Therefore, an increase in awareness, along with support from the government through reimbursement and innovation in products to develop a low-cost and effective treatment, are some elements expected to drive the market over the forecast period.

North America is Dominating the Market and is Expected to do the Same During the Forecast Period

North America currently dominates the market for urology devices, and it is expected to continue its stronghold for a few more years. Benign prostatic hyperplasia (BPH) is among the most untapped segments in the urology market. Several United States-based companies are working on upgrading their devices in this segment, either by collaboration or acquisition.

The region is experiencing a drastic increase in innovations related to diagnostic methodologies used for UTIs. According to the article published in Infectious Diseases Society of America in November 2020, by Pranita D. Tamma, during a routine checkup for a UTI, a woman was observed to be infected by E. coli that showed resistance to the last-resort antibiotic, Colistin. The discovery of Colistin-resistant bacteria was considered a major issue. In addition to that, the CDC, in collaboration with other organizations, developed guidelines for preventing catheter-associated UTIs and other healthcare-associated infections in the United States. UTIs are a substantial societal and personal burden, accounting for many medical visits in the United States each year. This condition drives the market by increasing sales of urology devices.

Thus, over the forecast period, technological advancements, a high percentage of urology cases in hospitals, and increasing funding are expected to be the major drivers for the growth of the urology devices market.

Urology Devices Market Competitor Analysis

The urology devices market is highly competitive and consists of several major players. With increasing technological advancements and product innovations, mid-size to smaller companies are expected to increase their market presence by introducing new devices at lesser prices. These companies, like Baxter, Boston Scientific, C. R. Bard, Medtronic, and Siemens, hold a substantial share in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Incidence of Urologic Conditions
    • 4.2.2 Rising Geriatric Population
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Policies for Validation of Medical Devices
    • 4.3.2 High Cost of Urology Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Instruments
      • 5.1.1.1 Dialysis Devices
      • 5.1.1.2 Endoscopes and Endovision Systems
      • 5.1.1.3 Lasers and Lithotripsy Devices
      • 5.1.1.4 Other Instruments
    • 5.1.2 By Consumables and Accessories
      • 5.1.2.1 Dialysis Consumables
      • 5.1.2.2 Guidewires and Catheters
      • 5.1.2.3 Stents
      • 5.1.2.4 Biopsy Devices
      • 5.1.2.5 Other Consumables and Accessories
  • 5.2 By Disease
    • 5.2.1 Kidney Diseases
    • 5.2.2 Urological Cancer and BPH
    • 5.2.3 Pelvic Organ Prolapse
    • 5.2.4 Other Diseases
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Dialysis Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Baxter International Inc.
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Cook Medical Incorporated
    • 6.1.5 Stryker Corporation
    • 6.1.6 Fresenius Medical Care AG & Co. KGaA
    • 6.1.7 Intuitive Surgical Inc.
    • 6.1.8 Karl Storz SE & Co. KG
    • 6.1.9 Medtronic PLC
    • 6.1.10 Olympus Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS